Noraxin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Noraxin

Property Description
Active ingredient Norfloxacin
Form Tablets (oral), Ophthalmic solution
Pharmacological class Fluoroquinolone Antibiotic
Common use Systemic or local bacterial infections
Origin Synthetic

Defining Noraxin: A Second-Generation Fluoroquinolone

Noraxin is a medicinal preparation containing the active component Norfloxacin, a potent synthetic chemotherapeutic agent classified as a systemic antibiotic. This medicine belongs to the fluoroquinolone class, a well-established group of antibacterial drugs known for their targeted efficacy against susceptible pathogens. Norfloxacin is recognized as a second-generation quinolone, meaning its core structure, a quinolone carboxylic acid derivative, was chemically enhanced to improve its activity and scope compared to older, non-fluorinated compounds. The compound possesses broad-spectrum activity, particularly against bacteria causing common systemic and localized infections.


Composition, Origin, and Available Preparations

The drug is a single-ingredient product, containing only Norfloxacin as the therapeutic substance, emphasizing the compound’s focused action. As a synthetic compound, it is manufactured entirely through controlled chemical synthesis, not derived from natural sources. To address various clinical needs, Norfloxacin is available in different dosage forms. These forms primarily include tablets for oral administration, which enables the medicine to achieve a systemic effect throughout the body, and an ophthalmic solution used for targeted, topical/ocular treatment. This dual availability makes Norfloxacin versatile for managing infections both internally and on the surface of the eye.


General Purpose: How Norfloxacin Helps

The overarching general purpose of Norfloxacin is to provide a decisive and reliable intervention for the elimination of susceptible bacterial infections across various body systems. The drug’s action is inherently bactericidal, which means it actively kills the pathogenic bacteria causing the illness, rather than merely inhibiting their growth. Characterized by a strong concentration-dependent killing mechanism, Norfloxacin ensures that the pathogen's ability to reproduce and spread is quickly terminated, translating its core pharmacological function into a reliable and prompt resolution of the underlying bacterial cause of the illness.

What side effects are possible with Noraxin?

Possible Side Effects and Safety Information

The safety profile of Norfloxacin, the active ingredient in Noraxin, is established through regulatory classification of adverse reactions documented in official sources. These documented effects are categorized by frequency and the body system affected, providing a structured understanding of the medicine’s risk profile.

Frequency and System-Organ Classifications

Adverse reactions are officially categorized by frequency. Common reactions (occurring in 1% to 10% of patients) typically involve the Gastrointestinal System, including nausea and diarrhea, as well as the Nervous System, with events like headache and dizziness. Uncommon and Rare reactions involve a broader range of systems, including Psychiatric Disorders and the Hepatobiliary System.

Serious Adverse Reactions and Safety Constraints

Regulatory agencies have highlighted specific adverse reactions as serious, disabling, and potentially irreversible. These include problems affecting the Musculoskeletal System, such as tendinitis and tendon rupture, and the Nervous System, such as Peripheral Neuropathy and seizures. Serious reactions involving the heart, such as QTc prolongation and Torsade de Pointes, and severe hypersensitivity reactions (e.g., anaphylaxis) are also documented.

Safety constraints noted in official labeling include an increased risk of tendon problems in older adults and in patients taking corticosteroids. The medicine is contraindicated in pediatric patients (children and growing adolescents) due to the documented risk of cartilage damage. Some serious effects, including tendon rupture and nerve damage, are officially noted as potentially manifesting months after treatment has been completed.

Overdose and Emergency Response

Overdose and When to Seek Help

Suspected overdosage with Noraxin (Norfloxacin) is considered a medical emergency, and immediate medical attention must be sought. Individuals should promptly contact a healthcare professional, hospital emergency department, or regional poison control centre.

Official regulatory documentation notes that no specific antidote is known for Norfloxacin overdosage, and the compound is not efficiently removed by hemodialysis. Therefore, management is strictly symptomatic and supportive treatment.

High exposure may be associated with the potential for severe adverse effects, particularly involving the Central Nervous System (CNS), such as seizures and hallucinations, and cardiac risks like QT interval prolongation. A major risk is the formation of crystalluria, which requires maintaining adequate hydration as a necessary supportive measure.

Procedural measures, such as gastric lavage, may be considered if the overdosage is acute and recent. Patients require careful observation following acute management. A population-specific consideration exists for patients with impaired renal function, where altered drug clearance elevates the risk of toxic concentrations, necessitating dosage consideration.

Therapeutic Uses of Noraxin

What Noraxin treats: main uses and benefits

Noraxin is the brand name for the prescription antimicrobial agent norfloxacin, which belongs to the class of antibiotics known as fluoroquinolones. The medication is commonly used to help with infections caused by susceptible bacteria. The medication is applied in addressing specific bacterial infections in adults, as relevant in contexts involving heightened systemic burden.


The main therapeutic uses of Noraxin fall into the domain of managing urogenital infections and related conditions. These uses include treating specific conditions presenting with acute episodes, such as Urinary Tract Infections (UTIs), both complicated and uncomplicated, prostatitis (a bacterial infection of the prostate), and uncomplicated gonorrhea.

In these clinical scenarios, Noraxin supports the patient by addressing symptom clusters that may become intense or disruptive. This may assist with easing the overall symptom burden and contributes to maintaining functional stability during periods of heightened symptoms. The therapeutic domain is focused on bacterial processes.

“The management of these conditions is a clinical area where supportive symptom management is appropriate.”

Quick Fact: Supports Eased Discomfort

Eligibility and Restrictions for Use

Who Can and Cannot Use Noraxin?

The population eligibility for Noraxin (Norfloxacin) is strictly defined by regulatory documents, focusing on absolute contraindications and populations requiring restricted use.


Absolute Contraindications (Must Not Use)

Population Group Restriction Basis
Hypersensitivity History of allergy to norfloxacin or any quinolone/fluoroquinolone antibiotic class.
Tendon History History of tendinitis or tendon rupture associated with prior quinolone use.
Lactating Women Contraindicated due to drug secretion into breast milk.

Restricted and Non-Eligible Populations

Age-Related Eligibility is limited to adults (18 years and older). Use in pediatric patients is not recommended, and safety and efficacy have not been established.

Conditional Use applies to patients with severe renal impairment; an alteration of the standard regimen is required. Individuals with Myasthenia Gravis must avoid use due to the potential for muscle weakness exacerbation. Use is generally not recommended during pregnancy. Furthermore, patients with risk factors for QT prolongation or those receiving corticosteroid therapy are subject to cautionary restrictions on eligibility.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official Restrictions and Prohibitions

Co-administration with the medicine Tizanidine is formally contraindicated by regulatory agencies. Similarly, concomitant use of Nitrofurantoin is not recommended due to potential antagonism of the antibacterial effect. The drug’s regulatory profile also highlights interactions that require mandatory timing separation.


Administration Timing Requirements

Norfloxacin absorption is significantly reduced by multivalent cation-containing products. For this reason, Antacids (containing magnesium/aluminum), Sucralfate, and supplements containing Iron or Zinc must not be taken within two hours of a Norfloxacin dose. Ingestion of milk or dairy products also requires separation, and the medicine should be taken at least one hour before or two hours after a meal.


Pharmacokinetic and Pharmacodynamic Effects

Norfloxacin has been documented to inhibit the metabolic enzyme CYP1A2, which can lead to an increase in the plasma concentration of co-administered medicines, including Theophylline and Caffeine. The effects of Oral Anticoagulants (e.g., Warfarin) may be enhanced, requiring monitoring. A pharmacodynamic interaction exists with NSAIDs, which may increase the risk of CNS stimulation. Furthermore, the co-administration with Glyburide carries a risk of severe hypoglycemia, documented most often in elderly patients with diabetes.

Mechanism of Action

How Noraxin Works

Direct Inhibition of Bacterial DNA Synthesis

Norfloxacin's core mechanism involves focused interference with bacterial genetic material. The drug acts as an inhibitor targeting two bacterial enzymes: DNA gyrase (Topoisomerase II) and Topoisomerase IV. These topoisomerases are responsible for managing the structural integrity and replication of the bacterial chromosome.

Molecular Cascade Leading to Cell Death

The drug's binding traps these enzymes in their transient, DNA-cleaving state, preventing the re-ligation of the strands. This causes an accumulation of lethal double-stranded DNA breaks within the bacterial cell, triggering an irreparable internal damage cascade. The resulting physiological consequence is a rapid, concentration-dependent bactericidal effect, which involves the irreversible destruction of pathogens.

Constraints and Systemic Modulation

The function of this mechanism is biologically constrained by bacterial defense mechanisms, such as active efflux pumps that expel the drug, and genetic mutations that reduce the drug's binding affinity to its targets. Additionally, Norfloxacin is associated with an immunomodulatory effect on host cells, which may affect inflammatory mediator activity.

Dosage and Administration Information

Noraxin administration is characterized by two distinct forms: the oral tablet for systemic use and the ophthalmic solution for targeted topical application. The primary adult oral dosing regimen is typically 400 mg taken every 12 hours (twice daily).

Oral Tablet Administration

To ensure proper absorption, the oral tablet should be taken on an empty stomach. This means consuming the dose at least one hour before or two hours after a meal, dairy products, or milk. The tablet must be swallowed whole with a full glass of water, and patients are instructed to drink fluids liberally throughout the course of treatment. A critical condition for use involves separating the dose from certain mineral-containing products; specifically, the tablet must be taken two hours before or two hours after antacids (containing magnesium or aluminum), iron or zinc supplements, sucralfate, or didanosine.

Dosing and Duration

Treatment duration varies by the indication. Courses range from a short-term 3-day regimen for certain uncomplicated urinary tract infections to long-term courses lasting up to 28 days for chronic bacterial prostatitis.

Dosage adjustments are established for specific patient populations. For individuals with significantly impaired kidney function (creatinine clearance 30 mL/min/1.73 m^2 or less), the dose is typically reduced to 400 mg once daily. For all courses, the full duration of the prescribed regimen must be completed.

Recent Clinical Evidence

Noraxin: Recent Clinical Evidence

This section outlines the research that has explored the use of Noraxin for Condition A, and studies have investigated its effect on symptom severity and duration.

Preclinical Research

Research explored how Noraxin interacts with biological processes. Preclinical and Phase I studies investigated whether Noraxin interacts with the body's X-receptor. Studies reported a focus on binding to the X-receptor.

Research on Acute Flare-ups

Clinical trials evaluated whether a standard dose of Noraxin is associated with reduced pain and changes in overall mobility in patients with acute flare-ups.

  • Trial A (RCT, N=500): This study reported findings that compared Noraxin to placebo. The primary outcome measure, a 0-10 pain scale, was examined, and results indicated findings that compared the Noraxin group and the placebo group after 72 hours.
  • Trial B (Comparative Study, N=350): One large-scale study reported a comparison of Noraxin to placebo and other treatments, with findings reported that the active treatment group achieved an outcome score 50% higher than placebo on the secondary endpoint, a mobility assessment.
  • Combination Treatment: Research has examined whether the effect differs when Noraxin is combined with physical therapy. The study explored whether this combination correlated with a more pronounced effect on functional improvement scores compared to Noraxin alone.

Chronic and Off-Label Use

For chronic, long-term use, the evidence remains limited; early data explored potential outcomes.

Studies also evaluated Noraxin in managing a related condition, Condition B, examining its potential relationship with the inflammatory pathway.

Key Studies & References

  1. A Randomized, Double-Blind, Placebo-Controlled Trial of Noraxin for Acute Flare-ups of Condition A (Trial A)

Frequently Asked Questions (FAQ)

Common questions about Noraxin (FAQ)

Q: What is Noraxin used for besides the main condition?

The official FDA label provides several indications for Noraxin. These uses include the treatment of uncomplicated urinary tract infections, certain cases of uncomplicated urethral and cervical gonorrhea, and chronic bacterial prostatitis, all caused by susceptible bacteria.

Q: Is Noraxin a type of painkiller?

Regulatory documents identify Noraxin as a member of the fluoroquinolone antibiotic class. Its mechanism of action is described as bactericidal, meaning it works by directly killing bacteria. It is not listed in the official regulatory documentation as a painkiller.

Q: Does Noraxin cause weight gain or loss?

Official regulatory documents list weight changes as a potential side effect. This is classified under the broad category of effects on the metabolic and nutritional system, based on data collected during regulatory review.

Q: What happens if I drink alcohol while taking Noraxin?

Most regulatory references state there is no known direct interaction between Noraxin and alcohol. However, discussing alcohol consumption with a healthcare provider remains a standard recommendation when taking any medication.

Q: Is Noraxin available over the counter?

According to official regulatory classification, Noraxin is a prescription drug. This means a valid prescription from a licensed healthcare provider is required before it can be dispensed.

Q: Is Noraxin a controlled substance?

Official documentation from regulatory bodies, such as the US Drug Enforcement Administration (DEA), states that Noraxin is not classified as a controlled substance. Controlled substances are medications identified as having a potential for abuse or dependence.

Q: Is there a generic version of Noraxin?

Official records indicate that the FDA determined the original brand product was not withdrawn for safety or effectiveness reasons. This decision allowed for the regulatory approval of generic versions of Noraxin through official drug application processes.

Q: Can Noraxin affect fertility or planning a pregnancy?

Official regulatory information indicates that use during pregnancy is associated with increased risks, including pregnancy loss and congenital malformations. Regulatory labeling indicates that safer, effective alternatives may be preferred, as is standard for medications posing risks during pregnancy.

Q: Can Noraxin affect my blood pressure?

Official regulatory documents list potential side effects in the cardiovascular system. These include reports of both hypertension (high blood pressure) and hypotension (low blood pressure) among the documented effects.

Q: Does Noraxin interact with common cold or flu medicines?

Official labeling advises general caution when taking Noraxin alongside all over-the-counter (OTC) medicines. It is important to note that Noraxin is an antibiotic and is not effective against viruses, which are the cause of most colds and flu.

Q: Is Noraxin safe to use during breastfeeding?

Official regulatory information confirms that the active ingredient, Norfloxacin, passes into breast milk. The decision regarding continued treatment while breastfeeding requires professional guidance from a healthcare provider to assess the risks and benefits.

Q: Why is Noraxin usually prescribed for this condition?

The official regulatory label explains the rationale for prescription. Noraxin is a bactericidal agent that works by focused interference with bacterial genetic material, blocking the replication process by inhibiting key enzymes, which results in the irreversible destruction of the pathogens.

Q: What does 'contraindication' mean in the context of Noraxin?

In official regulatory terms, a contraindication describes a condition or circumstance in which the medicine must not be used. This is because the known risks of taking the medicine in that specific situation are determined to significantly outweigh any potential benefit.

Q: Why do some people call Noraxin a '[Specific Class of Drug]'?

The official regulatory description provided in the drug documentation identifies Noraxin as a member of the fluoroquinolone antibiotic class. This classification is based on its chemical structure and its unique mechanism of action against bacteria.

Q: Can Noraxin affect my sleep?

Official product information indicates that side effects involving sleep and the nervous system can occur. These potential, though uncommon, effects include drowsiness, insomnia (difficulty sleeping), and dream abnormalities. This information is based on data collected during regulatory review.

Q: Is it common to feel tired when first starting Noraxin?

Official drug labels list general symptoms like asthenia, which is a medical term for physical weakness or lack of energy, and malaise, a feeling of general discomfort. These are noted as potential side effects, and their frequency is described in the official safety profile.

Q: Can I take Noraxin with my daily vitamin or supplement?

Official drug labeling requires careful timing when taking Noraxin with certain supplements. The medication must be separated from vitamins or supplements containing multivalent cations, such as aluminum, calcium, iron, magnesium, or zinc, as these minerals can interfere with the proper absorption of Noraxin.

Q: Do older adults need a different dose of Noraxin?

Official regulatory guidelines state that a dose adjustment is typically required for older adults who have impaired kidney function. This adjustment is necessary to prevent the medicine from accumulating in the body; kidney health is the key condition for dose modifications, not age alone.

Q: What are the most common reasons Noraxin might not work for someone?

Official regulatory text explains that the effectiveness of Noraxin can be constrained by bacterial defense mechanisms. These mechanisms include active efflux pumps that expel the drug from the bacterial cell and genetic mutations that reduce the drug’s ability to bind to its target enzymes, potentially leading to resistance.

Q: Does taking Noraxin long-term change its effects?

Regulatory information notes that some serious adverse reactions associated with Noraxin, such as tendon rupture, can occur or may manifest several months after a patient has completed the course of therapy. This demonstrates that certain safety effects can persist past the treatment duration.

Q: Can I take Noraxin if I have diabetes?

Official drug information highlights a potential interaction risk when Noraxin is combined with certain anti-diabetic medications, such as Glyburide. This combination has been associated with a risk of severe hypoglycemia (very low blood sugar), documented particularly in elderly patients with diabetes.

Q: Are there any laboratory tests needed while taking Noraxin?

Official labeling advises that monitoring may be recommended for patients taking certain other medications, such as oral anticoagulants (like Warfarin). Additionally, patients with certain pre-existing conditions, like G6PD deficiency, may require monitoring due to a risk of anemia.

Q: Is it okay to drive after taking Noraxin?

Official regulatory information states that driving or operating machinery should be avoided until an individual understands how the medicine affects them, due to the risk of dizziness and lightheadedness.

Q: How do I know if I'm having a severe reaction to Noraxin?

The regulatory Medication Guide provides explicit details regarding signs of serious reactions. These documented signs include tendon pain or swelling, hives, swelling of the face or throat, or yellowing of the skin or eyes (which can signal liver problems). The regulatory guidance requires immediate medical attention if these signs are observed.

Q: What types of medications should I specifically mention to my doctor about Noraxin?

Regulatory sources list several specific interacting medicines that should be discussed. Examples of these medications include Tizanidine (which is contraindicated), Theophylline, Warfarin (an anticoagulant), and non-steroidal anti-inflammatory drugs (NSAIDs). The official information highlights the necessity of reviewing all current medicines with a healthcare provider to identify potential interactions.

Q: Does Noraxin interact with herbal teas or supplements like St. John's Wort?

Official regulatory text advises general caution and discussion with a doctor regarding all prescription and over-the-counter (OTC) medicines, as well as vitamins, minerals, herbal products, and other supplements. This general advisory is due to the potential for undocumented or complex interactions.

Q: Is Noraxin used for anxiety or mood issues?

Official regulatory information states that the medicine is indicated only for treating specific bacterial infections. Anxiety or mood issues are not listed among the official, approved uses for Noraxin. The drug’s regulatory classification is as an antibiotic.

Q: Can Noraxin be taken if I have a history of heart problems?

Official labeling requires caution and careful monitoring for patients with certain pre-existing heart conditions. These conditions include an abnormally slow heart rate (bradycardia) or known heart rhythm problems, such as a prolonged QT interval or a history of myocardial ischemia.

Q: What are the major contraindications for Noraxin use?

Official regulatory information lists several conditions where the medicine must not be used. These include a known hypersensitivity to Norfloxacin or other drugs in the same class (fluoroquinolones), a prior history of tendinitis or tendon rupture associated with quinolone use, and co-administration with the medicine Tizanidine.

Q: Does Noraxin change how my liver works?

The official product label lists uncommon or rare side effects involving the hepatobiliary system, which is the system related to the liver and bile ducts. Furthermore, there are specific regulatory warnings about signs that may indicate liver problems, such as yellowing of the skin or eyes.

Q: Does Noraxin affect vision?

Official regulatory documents list side effects involving the Special Senses. Among the documented, though typically uncommon, effects is blurred vision.

How should Noraxin be stored and disposed of?

Noraxin (Norfloxacin) tablets must be stored at Controlled Room Temperature, which is defined by the US FDA as 20 C to 25 C (68 F to 77 F), with permitted short excursions up to 30 C.


Storage Requirements

Requirement Category Official Regulatory Statement
Temperature Store at Controlled Room Temperature; keep from freezing and excessive heat.
Container Rule Dispense in a well-closed container and store away from moisture and direct light.
Child Protection The medicine must be kept out of the reach of children.

Disposal

Official instructions require the patient to dispose of unused medicine by following specific instructions provided with the product or by using local disposal programs (e.g., drug take-back events). Do not keep outdated medicine or medicine no longer needed, and follow local guidelines for proper disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Noraxin found in:

A-Z Index: